CVEO vs XWIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CVEO exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating deteriorating financial health. While the stock has seen recent price appreciation, it is fundamentally overvalued with an extreme PEG ratio of 191.60 and a forward P/E of 58.26. Profitability remains negative with an ROE of -9.76% and a consistent track record of missing earnings estimates (0/4 beats in the last year). The current valuation is disconnected from the company's operational performance and poor deterministic health scores.
XWIN exhibits severe fundamental distress, highlighted by a critical Piotroski F-Score of 1/9, indicating poor financial health across nearly all dimensions. There is a massive disconnect between the company's fundamentals—characterized by negative revenue growth (-11.8%) and deep operating losses (-59.27% margin)—and its 1-year price surge of 772.3%. With a Price/Book ratio of 18.24 and Price/Sales of 20.44, the stock is trading at an extreme speculative premium that is unsupported by its current earnings trajectory or growth profile.
Compare Another Pair
Related Comparisons
CVEO vs XWIN: Head-to-Head Comparison
This page compares Civeo Corporation (CVEO) and XMax Inc. (XWIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.